Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)

The immune checkpoint blockade is an effective strategy to enhance the anti-tumor T cell effector activity, thus becoming one of the most promising immunotherapeutic strategies in the history of cancer treatment. Several immune checkpoint inhibitor have been approved by the FDA, such as anti-CTLA-4,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Sheng, Xiong, Gui, Zhao, Shimei, Tang, Yanbo, Tang, Hua, Wang, Kaili, Liu, Hongjing, Lan, Ke, Bi, Xiongjie, Duan, Siliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797440/
https://www.ncbi.nlm.nih.gov/pubmed/33416134
http://dx.doi.org/10.3892/ijmm.2020.4817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797440/
https://www.ncbi.nlm.nih.gov/pubmed/33416134
http://dx.doi.org/10.3892/ijmm.2020.4817

Ejemplares similares